M2 Pharma - Therapy Areas - Infectious Diseases

Co-Diagnostics raises USD5m from registered direct offering priced at-the-market

29 January 2020 - Molecular diagnostics company Co-Diagnostics Inc (Nasdaq:CODX) said on Tuesday that it has closed its registered direct offering of 3,448,278 shares of common stock.Under the registe...

Pfizer Vaccines Launches Global Centers of Excellence Network to Conduct Real-World Research on Vaccine-Preventable Diseases Affecting Adults

27 January 2020 - - US-based pharmaceutical company Pfizer Inc. (NYSE: PFE) has launched its Vaccines Division's Centers of Excellence Network, a global programme of collaborations with academic ...

Moderna Receives Funding Award from CEPI to Accelerate Development of Messenger RNA Vaccine Against Novel Coronavirus

27 January 2020 - - US-based clinical stage biotechnology company Moderna, Inc., (NASDAQ: MRNA) has forged a new collaboration to develop an mRNA vaccine against the novel coronavirus (2019-nCoV), the...

European Clinical Research Centre AP-HP and IQVIA Collaborate to Launch Clinical Investigation Site

27 January 2020 - - European clinical research centre Assistance Publique Hôpitaux de Paris (AP-HP) is joining US-based health technology and human data science company IQVIA to launch the Paris...

Co-Diagnostics expects USD5.0m from registered direct offering priced at-the-market

27 January 2020 - Molecular diagnostics company Co-Diagnostics Inc (Nasdaq:CODX) reported on Friday the issuance of 3,448,278 shares of its common stock under definitive agreements with institutional ...

Co-Diagnostics Designs Test for New Coronavirus Using CoPrimer Platform

24 January 2020 - - US-based molecular diagnostics company Co-Diagnostics, Inc. (NASDAQ: CODX) has completed principle design work for a PCR screening test for new coronavirus, 2019-nCoV, intende...